Home » Emerson and Optimal Join Forces to Produce a Full PAT Solution for Life Sciences Industries
Emerson and Optimal Join Forces to Produce a Full PAT Solution for Life Sciences Industries
PharmaManufacturing.com
01/14/2010
Emerson Process Management and Optimal Industrial Automation Ltd have formed an alliance that integrates Optimal’s synTQ PAT data management package with Emerson’s PlantWeb digital plant architecture. The alliance delivers a Process Analytical Technology (PAT) solution that leverages existing automation investments and has the scalability to deliver stand-alone PAT solutions for R&D labs, or deliver an integrated DeltaV or Syncade PAT solution for manufacturing floors.
“Emerson now has a full PAT solution,” said Saroj Patnaik, director, life sciences, from Emerson’s global industry solutions group. “Global trends like changing disease profiles, the increasing aging population and government run health care will demand more-for-less manufacturing methods. Producing more safe products in smaller quantities across the world in a cost effective manner is a daunting task for our customers. We believe PAT has the promise to be the holy grail of real-time release of products. The Emerson/synTQ alliance will help our customers meet these cost pressures by leveraging their existing automation investment.”
The synTQ data management package, in concert with DeltaV automation system, monitors the manufacturing process holistically and adjusts the process to continually optimize product quality. This technology requires both accurate and real-time information as to how critical-to-quality product attributes are varying as the process progresses, and adjusts the process to continually optimize these parameters. Optimal’s synTQ software product collects real-time instrument analytical data together with the control system’s univariate data and derives the necessary critical-to-quality product information in real-time. The trends in this critical-to-quality information can then be used by synTQ and the control system to steer the process to improve product quality together with timely manufacturing execution.
“We are gratified to have this formal alliance in place with Emerson,” said Martin Gadsby, director of Optimal Industrial Automation. “This alliance is a good fit for us. This alliance expands the synTQ package with a global sales and support capability from Emerson. Additionally, synTQ provides our clients with a best-in-class PAT Data Management System with the full support of Emerson. Our projected development path for the synTQ package is to more tightly integrate it with Emerson’s PlantWeb architecture. The important value to the customer is its ability to integrate seamlessly to customers’ preferred analytical instruments and lab systems.
About Emerson Process Management
Emerson Process Management (www.emersonprocess.com), an Emerson business, is a leader in helping businesses automate their production, processing and distribution in the chemical, oil and gas, refining, pulp and paper, power, water and wastewater treatment, mining and metals, food and beverage, pharmaceutical and other industries. The company combines superior products and technology with industry-specific engineering, consulting, project management and maintenance services. Its brands include PlantWeb, Syncade, Fisher, Rosemount, Micro Motion, Daniel, DeltaV, Ovation, and AMS Suite.
About Emerson
Emerson (NYSE:EMR), based in St. Louis, Missouri (USA), is a global leader in bringing technology and engineering together to provide innovative solutions to customers through its network power, process management, industrial automation, climate technologies, and appliance and tools businesses. Emerson’s sales in fiscal 2009 were $20.9 billion. The company is ranked 94th on the Fortune 500 list of America’s largest companies. For more information, visit www.Emerson.com.
About Optimal Industrial Automation
Established over 22 years ago, Optimal is a leading UK based company focused on factory and process automation with specialties in the life sciences, chemical, food & beverage plus power generation industries including nuclear, energy from waste and CHP. Having innovation at its heart with a strong desire to help clients optimize their processes, Optimal embarked on the development of a product specifically for enabling Process Analytical Technology in a regulated environment. Continuous innovation and development by a dedicated team over an 8 year period has resulted in the industry leading PAT Data Management software package – synTQ. synTQ is the most mature product in this market space and an active development plan will ensure it retains its lead.
More News:
-
02/09/2012
Watchdog Fines Ernst & Young $2 million Over Medicis Pharma Corp. AuditsFrom Reuters.com
The watchdog board for corporate auditors on Wednesday said it has imposed a $2 million penalty, its largest fine ever, on accounting and consulting firm Ernst & Young LLP in a settlement involving past audits of Medicis Pharmaceutical Corp.
-
02/09/2012
FDA Issues Draft Guidance on Biosimilar Product Development
The U.S. Food and Drug Administration today issued three draft guidance documents on biosimilar product development to assist industry in developing such products in the United States.
-
02/08/2012
Biomedical Industry Loses Momentum in California, According to 2012 Report
Innovation slows as productivity in the Biomedical industry declines
-
02/02/2012
Pfizer Baby Boom? Pfizer's Official StatementFrom Pharmalot.com
About nine months from now, a new phenomenon may appear at a hospital near you: the Pfizer baby. Why? The drugmaker has taken the embarrassing step of recalling 1 million packets of birth control pills due to a packaging error. Hear EVP and CMO, Freda Lewis-Hall's read Pfizer's official statement.
-
02/02/2012
News: AstraZeneca To Cut 7,300 JobsFrom MarketWatch.com
Drug firm AstraZeneca on Thursday said it would cut approximately 7,300 jobs as part of an ongoing initiative to reduce costs and drive innovation.
-
02/01/2012
Pfizer Recalls 1 Million Birth Control Packs for Error That Could Cause Unintended PregnancyFrom WashingtonPost.com
Pfizer Inc. is recalling 1 million packets of birth control pills due to a packaging error that could raise the risk of an accidental pregnancy by leaving women with an inadequate dose. The problem affects 14 lots of Lo/Ovral-28 tablets and 14 lots of generic Norgestrel and Ethinyl Estradiol tablets. Both products are manufactured by Pfizer and marketed in the U.S. by Akrimax Rx Products under the Akrimax Pharmaceuticals brand.
-
01/26/2012
News: Abbott Labs Cuts 700 Manufacturing JobsFrom WashingtonPost.com
Medical device and drugmaker Abbott Laboratories said Wednesday it will lay off 700 employees as part of ongoing restructuring efforts. A company spokeswoman said most of the layoffs will affect employees who manufacture the company’s heart stents and diagnostic tests.
- 01/24/2012 ISPE Announces 2012 FOYA Winners
- 01/24/2012 Genzyme Gains Approval for Framingham Site, a Boost to Fabrazyme Production
-
01/19/2012
Big Pharma Execs May Wish They'd Never Heard Of Paula DeenFrom Forbes.com
Novo Nordisk has nabbed Paula Deen as a new spokeswoman to help raise awareness about type 2 diabetes. Many in the drug industry wish it weren’t so, but without major legal and regulatory changes, such matches between celebs and drug firms are as certain as the sun rising in the east.
- All news »
Get Connected Now!
- Featured White Papers

Print page